Osimertinib(Tagrisso)

Another NameAZD9291、Tagrix、Osicent、Luciosim、奥斯替尼、塔格瑞斯、奥希替尼

IndicationsSuitable for locally advanced or metastatic non-small cell lung cancer (NSCLC) patients with EGFRT790M mutation positivity.